Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain.: Lithium treatment modifies these changes

被引:110
作者
Husum, H
Mathé, AA [1 ]
机构
[1] Karolinska Inst, Inst Physiol & Pharmacol, Div Pharmacol, SE-17177 Stockholm, Sweden
[2] Karolinska Inst, Inst Clin Neurosci, SE-17177 Stockholm, Sweden
[3] Rigshosp, Dept Psychiat, Neuropsychiat Lab, DK-2100 Copenhagen, Denmark
关键词
maternal deprivation; NPY; CRH; corticosterone; stress; lithium; rat;
D O I
10.1016/S0893-133X(02)00363-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Experiences of early life stress are more prevalent among depressed patients than healthy controls. Neuropeptide Y (NPY) was suggested to play a role in the pathophysiology of depression. Consequently, we investigated in adult rats the effects of maternal deprivation for 3 h/day during postnatal days (PND) 2-14 and of dietary lithium during PND 50-83 on brain levels of NPY-like immunoreactivity V). Brain levels of corticotropin-releasing hormone (CRH) and serum corticosterone were also measured. Maternal deprivation reduced NPY-LI levels in the hippocampus and the striatum but increased NPY-LI and CRH-LI levels in the hypothalamus. Lithium treatment counteracted the effect of maternal deprivation in the hippocampus and striatum by increasing NPY-LI levels. In the hypothalamus, lithium tended to decrease CRH-LI but further increased levels of NPY-LI; it also increased scrum corticosterone levels. The results suggest that early life stress has long-term effects on brain NPY with implications for the development of depression/vulnerability to stress, and that one therapeutic mechanism of action of lithium is to increase brain NPY. (C) 2002 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:756 / 764
页数:9
相关论文
共 72 条
[1]   Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia [J].
Agid, O ;
Shapira, B ;
Zislin, J ;
Ritsner, M ;
Ritsner, M ;
Hanin, B ;
Murad, H ;
Troudart, T ;
Bloch, M ;
Heresco-Levy, U ;
Lerer, B .
MOLECULAR PSYCHIATRY, 1999, 4 (02) :163-172
[2]   NEUROPEPTIDE-Y IN THE HYPOTHALAMUS - EFFECT ON CORTICOSTERONE AND SINGLE-UNIT ACTIVITY [J].
ALBERS, HE ;
OTTENWELLER, JE ;
LIOU, SY ;
LUMPKIN, MD ;
ANDERSON, ER .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (02) :R376-R382
[3]   The role of corticotropin-releasing factor in depression and anxiety disorders [J].
Arborelius, L ;
Owens, MJ ;
Plotsky, PM ;
Nemeroff, CB .
JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) :1-12
[4]  
BAASTRUP PC, 1970, LANCET, V2, P326
[5]   DEXAMETHASONE TREATMENT INCREASES NEUROPEPTIDE-Y LEVELS IN RAT HYPOTHALAMIC NEURONS [J].
CORDER, R ;
PRALONG, F ;
TURNILL, D ;
SAUDAN, P ;
MULLER, AF ;
GAILLARD, RC .
LIFE SCIENCES, 1988, 43 (23) :1879-1886
[6]  
Ehlers C L, 1997, Depress Anxiety, V6, P1
[7]   Neuropeptide Y levels in ethanol-naive, alcohol-preferring, and nonpreferring rats and in Wistar rats after ethanol exposure [J].
Ehlers, CL ;
Li, TK ;
Lumeng, L ;
Hwang, BH ;
Somes, C ;
Jimenez, P ;
Mathé, AA .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 22 (08) :1778-1782
[8]   Mammalian neural stem cells [J].
Gage, FH .
SCIENCE, 2000, 287 (5457) :1433-1438
[9]  
GHOSH D, 1990, Indian Journal of Physiology and Pharmacology, V34, P263
[10]  
GJERRIS A, 1992, J PSYCHIATR NEUROSCI, V17, P23